Dr. Thomas McGinn answers questions on comorbidities that are key factors in the acuity of COVID-19
Dr. Thomas McGinn, the director of Health Innovations & Outcomes Research at Feinstein Institutes, spoke with News 12's Elizabeth Hashagen and answered COVID-19 questions from viewers.
•
Apr 29, 2020, 1:38 PM
•
Updated 1,901 days ago
Share:
Dr. Thomas McGinn, the director of Health Innovations & Outcomes Research at Feinstein Institutes, spoke with News 12's Elizabeth Hashagen and answered COVID-19 questions from viewers.
Dr. McGinn was co-author on a JAMA paper about a study that linked hypertension, obesity and diabetes as comorbidities (the simultaneous presence of two chronic diseases or conditions in a patient) as key factors in the acuity of COVID-19 in some patients.
More from News 12
2:09
Suffolk PD: Knife-wielding man fatally shot while approaching victim to stab him again
1:39
Hot, humid and stormy week ahead on Long Island
11:00
Power & Politics: 1-on-1 with NYC mayoral candidates Zohran Mamdani and Curtis Sliwa
2:00
'State-of-the-art' police training village officially opens in Nassau County
0:30
Authorities: Teen fleeing police on e-bike fatally struck by hit-and-run driver in North New Hyde Park
0:32
